2002: Successful Approaches to Eosinophilic Esophagitis (EoE): Long-Term Management Dilemmas
Eosinophilic esophagitis (EoE) continues to increase in prevalence. Allergists are now frequently being asked to actively participate in the management of children and adults with EoE. While several management approaches, including PPIs, dietary restriction therapies and swallowed topical corticosteroids, are clearly documented to successfully treat patients with EoE, most of the evidence is based on short-term trials. Very little guidance exists regarding long-term management of these patients. Allergists are often faced with tough decisions, such as: when, and how often, to perform food challenges in patients on dietary restriction therapies; how long to continue swallowed topical corticosteroids and whether they can decrease the dose over time; how to incorporate combination therapies in the long-term care of EoE patients; and balancing long-term therapy choices with the patient's individual lifestyle. Finally, maintaining coordination of care between the allergist and the gastroenterologist in this disease is crucial. This seminar will review the available data on these topics, and allow for discussion of them with an allergist/immunologist and a gastroenterologist.
Credit claiming for this activity will be available through December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.
- Nurse Practitioners
- Allied Health Professionals
Upon completion of this activity, participants should be able to:
- Evaluate various long-term management options for patients with EoE
- Discuss ways to coordinate long-term care between the allergist and the gastroenterologist in EoE
- Outline how to apply drug challenges and desensitization in patients
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to1.50 Contact Hours.
CREDIT CLAIMING PERIOD
Credit claiming for this activity will expire at 11:59 pm on December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at email@example.com
Activity-related questions should be directed to firstname.lastname@example.org.
- 1.00 AttendanceAttendance credit.
- 1.00 CECE credit.
- 1.00 CMECME credit.
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.
Internet Explorer is no longer supported.